EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Poor prognosis of hepatocellular carcinoma patients—how, why, and what?

Vishal G Shelat iD

Journal of Gastrointestinal Oncology · 2024-10 · 15 (5) · 2372-2375

DOI: 10.21037/jgo-24-595 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Gastrointestinal Oncology, 2024-10. Verfasst von Vishal G Shelat. Beteiligte Einrichtung: Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hepatocellular carcinoma (HCC)Hippo pathwayYes-associated protein (YAP)

Autor:innen und Institutionen

  • Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore.

ORCID-Profile: Vishal G Shelat

Zitieren

APA

Shelat, V. G. (2024). Poor prognosis of hepatocellular carcinoma patients—how, why, and what?. Journal of Gastrointestinal Oncology, 15(5), 2372-2375. https://doi.org/10.21037/jgo-24-595

Vancouver

Shelat VG. Poor prognosis of hepatocellular carcinoma patients—how, why, and what?. Journal of Gastrointestinal Oncology. 2024;15(5):2372-2375. doi:10.21037/jgo-24-595

BibTeX
@article{Shelat2024,
  author = {Shelat, Vishal G},
  title = {Poor prognosis of hepatocellular carcinoma patients—how, why, and what?},
  journal = {Journal of Gastrointestinal Oncology},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {2372--2375},
  doi = {10.21037/jgo-24-595}
}
Kostenlos starten →